Apyx Medical Corporation (APYX)

1.4000 -0.0300 (-2.10%) At close: 04:00PM EDT

Apyx Medical Corporation

5115 Ulmerton Road
Clearwater, FL 33760-4004
United States
727 384 2323
https://apyxmedical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 252

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Charles D. Goodwin II	President, CEO & Director	813.13k	N/A	1967
Mr. Matthew C. Hill CPA	CFO, Treasurer & Secretary	445.95k	N/A	1969
Mr. Moshe Citronowicz	Senior Vice President	405.47k	N/A	1953
Mr. Todd Hornsby	Executive Vice President	561.77k	N/A	1977

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Corporate governance

Apyx Medical Corporation’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.